After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

The lawyers who negotiated a $69 million settlement with UnitedHealth Group Inc. over the Wells Fargo & Co. target date funds ...

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

UnitedHealth raised its dividend and replaced its CEO amid scrutiny over Medicare billing and a nearly 40% stock decline this ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...